Notes
4,5-Bis(r-h ydr oxyben zyl)-1-m eth yl-2-ph en ylim idazole (7).
J . Org. Chem., Vol. 67, No. 8, 2002 2701
1422 (w), 1262 (s), 749 (s) cm-1; 1H NMR (CDCl3) δ 2.77 (s. 3H),
3.87 (s, 3H), 10.06 (s, 1H), 10.28 (s, 1H); MS (EI) m/z 184 (M+,
35), 156 (74), 141 (29), 109 (100), 83 (87). Anal. Calcd for C7H8N2-
SO2: C, 45.64; H, 4.38; N, 15.21. Found: C, 46.00; H, 4.48; N,
15.05.
A 2 M solution of i-PrMgCl in THF (1.46 mL, 2.92 mmol) was
instilled into a cooled (0-5 °C; ice/water) solution of the diiodide
1 (500 mg, 1.22 mmol) in dry THF (20 mL) under an argon
atmosphere over a period of ca. 10 min. The resulting solution
was allowed to warm to rt and stirred for 1 h, and then neat
benzaldehyde (0.30 mL, 2.95 mmol) was slowly added at such a
rate that the internal temperature did not exceed 30 °C. After
being stirred for a further 2 h, saturated aqueous NH4Cl solution
(0.3 mL) was added, and the mixture was diluted with CH2Cl2
(100 mL), dried over MgSO4, and evaporated in vacuo at 40 °C.
HPLC chromatography (4:1 EtOAc/heptane) yielded the two
diastereoisomers of the title compound 7:
1-Eth oxym eth yl-4,5-bis(r-h yd r oxyben zyl)-2-p h en ylim i-
d a zole (12). Diastereoisomer A (144 mg from 500 mg of diiodide
4, 0.35 mmol, 31%): mp 80-83 °C; IR νmax 3650 (w), 3061 (w),
2976 (w), 1602 (w), 1492 (m), 1449 (m), 1378 (m), 1023 (m), 696
(s) cm-1; H NMR (CDCl3) δ 1.08 (t, J ) 8 Hz, 3H), 3.16-3.33
1
(m, 2H), 4.79 (d, J ) 8 Hz, 1H), 5.05 (d, J ) 8 Hz, 1H), 5.85 (s,
1H), 6.08 (s, 1H), 7.16-7.63 (m, 15H); MS (EI) m/z 414 (M+, 4),
396 (17), 337 (55), 105 (72), 77 (100). Anal. Calcd for C26H26N2O3‚
0.5H2O: C, 73.74; H, 6.43; N, 6.61. Found: C, 73.91; H, 6.57; N,
6.47.
Diastereoisomer A (154 mg, 0.42 mmol, 34%); mp 142-145
°C dec; IR νmax 3400 (w), 3026 (w), 1602 (w), 1473 (m), 1449 (m),
1394 (m), 1024 (m), 696 (s) cm-1
;
1H NMR (CDCl3) δ 2.3-3.4
Diastereoisomer B (130 mg from 500 mg of diiodide 4, 0.31
mmol, 28%): mp 70-73 °C; IR νmax 3650 (w), 3061 (w), 2976
(w), 1602 (w), 1492 (m), 1449 (m), 1378 (m), 1023 (m), 696 (s)
(bs, 2H, exch. with D2O), 3.32 (s, 3H), 5.85 (s, 1H), 6.07 (s, 1H),
7.13-7.53 (m, 15H); MS (EI) m/z 370 (M+, 4), 352 (76), 275 (50),
247 (22), 77 (100). Anal. Calcd for C24H22N2O2‚1.0H2O: C, 74.21;
H, 6.23; N, 7.21. Found: C, 74.10; H, 6.33; N, 7.18.
cm-1; H NMR (CDCl3) δ 1.07 (t, J ) 8 Hz, 3H), 3.16-3.27 (m,
1
2H), 4.75 (d, J ) 8 Hz, 1H), 5.00 (d, J ) 8 Hz, 1H), 5.99 (s, 1H),
6.15 (s, 1H), 7.20-7.59 (m, 15H); MS (EI) m/z 414 (M+, 2), 396
(13), 337 (28), 105 (63), 77 (100). Anal. Calcd for C26H26N2O3‚
0.2H2O: C, 74.69; H, 6.36; N, 6.70. Found: C, 74.72; H, 6.49; N,
6.69.
Diastereoisomer B (168 mg, 0.45 mmol, 37%): mp 142-145
°C dec; IR νmax 3600 (w), 3030 (w), 1601 (w), 1471 (m), 1450 (m),
1396 (m), 1023 (m), 696 (s) cm-1 1H NMR (CDCl3) δ 3.28 (s,
;
3H), 5.99 (s, 1H), 6.06 (s, 1H), 7.13-7.51 (m, 15H); MS (EI) m/z
370 (M+, 4), 352 (37), 275 (27), 247 (19), 77 (100). Anal. Calcd
for C24H22N2O2‚1.5H2O: C, 72.52; H, 6.34; N, 7.05. Found: C,
72.31; H, 6.05; N, 6.95.
2-Ch lor o-1-eth oxym eth yl-4,5-bis(r-h yd r oxyben zyl)im i-
d a zole (13). Diastereoisomer A (79 mg from 400 mg of diiodide
5, 0.27 mmol, 22%): IR νmax 3350 (w), 3031 (w), 2980 (w), 1602
(w), 1491 (m), 1472 (m), 1174 (m), 1105 (s), 696 (s) cm-1; 1H NMR
(CDCl3) δ 1.12 (t, J ) 8 Hz, 3H), 3.43 (m, 3H, 1H exch. with
D2O), 4.00 (bs, 1H, exch. with D2O), 4.83 (d, J ) 12 Hz, 1H),
5.08 (d, J ) 12 Hz, 1H), 5.79 (s, 1H), 6.08 (s, 1H), 7.16-7.44 (m,
10H); MS (CI) m/z 373 (M+ + H, 100), 355 (23). Anal. Calcd for
C20H21N2O3Cl‚2.0H2O: C, 58.75; H, 6.16; N, 6.85. Found: C,
58.64; H, 5.86; N, 6.64.
All other dianion reactions were performed using essentially
identical conditions (2.4 equiv of both i-PrMgCl and quenching
agent, etc.) with the following exceptions. After addition of the
electrophile N-methyl-N-(2-pyridyl)formamide, the reaction mix-
tures were stirred for 3.5 h before addition of aqueous NH4Cl.
Dry column chromatography18 was used to purify the dicarbox-
aldehydes 8 and 11 (1:4 EtOAc/heptane) and product 10 (4:1
EtOAc/heptane).
1-Met h yl-2-p h en ylim id a zole-4,5-d ica r b oxa ld eh yd e (8)
(157 mg from 1.0 g of diiodide 1, 0.73 mmol, 30%): IR υmax 3056
(w), 2960 (w), 1695 (m), 1668 (m), 1470 (m), 1299 (m), 749 (s)
cm-1; 1H NMR (CDCl3) δ 4.02 (s, 3H), 7.53-7.70 (m, 4H), 10.15
(s, 1H), 10.48 (s, 1H); MS (EI) m/z 214 (M+, 12), 186 (58), 116
(33), 83 (100). Anal. Calcd for C12H10N2O2‚0.1H2O: C, 66.72; H,
4.76; N, 12.97. Found: C, 66.78; H, 4.79; N, 12.76.
Diastereoisomer B (73 mg from 400 mg of diiodide 5, 0.24
mmol, 21%): IR νmax 3350 (w), 3040 (w), 2980 (w), 1602 (w), 1493
(m), 1473 (m), 1174 (m), 1105 (s), 696 (s) cm-1; 1H NMR (CDCl3)
δ 1.13 (t, J ) 8 Hz, 3H), 3.28 (bs, 1H), 3.41 (m, 2H), 4.03 (bs,
1H), 4.80 (d, J ) 12 Hz, 1H), 5.05 (d, J ) 12 Hz, 1H), 5.88 (s,
1H), 6.13 (s, 1H), 7.27-7.47 (m, 10H); MS (CI) m/z 373 (M+
+
H, 100), 355 (25); HRMS (EI) calcd for C20H21N2O3Cl 372.1241,
found 372.1229.
2-(4′-Ch lor op h en yl)-4,5-b is(r-h yd r oxyb en zyl)-1-m et h -
ylim id a zole (9). Diastereoisomer A (132 mg from 500 mg of
diiodide 2, 0.33 mmol, 29%): mp 147-149 °C dec; IR νmax 3460
1-Eth oxym eth yl-4,5-bis(r-h yd r oxyben zyl)-2-m eth ylim i-
d a zole (14). Diastereoisomer A (64 mg from 500 mg of diiodide
6, 0.18 mmol, 14%): IR νmax 3350 (w), 3060 (w), 2977 (w), 1586
(w), 3030 (w), 1603 (w), 1466 (m), 1092 (m), 722 (s) cm-1
;
1H
(w), 1493 (m), 1449 (m), 1185 (m), 1097 (m), 697 (s) cm-1 1H
;
NMR (CDCl3) δ 3.31 (s, 3H), 3.35-4.0 (bs, 2H, exch. with D2O),
5.83 (s, 1H), 6.07 (s, 1H), 7.11-7.47 (m, 14H); MS (EI) m/z 404
(M+, 7), 386 (92), 309 (61), 105 (45), 77 (100). Anal. Calcd for
NMR (CDCl3) δ 0.99 (t, J ) 8 Hz, 3H), 2.27 (s, 3H), 3.15 (q, J )
8 Hz, 2H), 4.81 (bs, 2H), 4.97 (q, J ) 12 Hz, 2H), 5.99 (s, 1H),
6.20 (s, 1H), 7.17-7.47 (m, 10H); MS (EI) m/z 352 (M+, 2), 334
(10), 288 (20), 275 (13), 77 (77), 59 (100); HRMS (Auto CI) calcd
for C21H24N2O3 353.1865, found 353.1885.
C
24H21N2O2Cl‚1.8H2O: C, 65.92; H, 5.67; N, 6.41. Found: C,
66.00; H, 5.36; N, 6.18.
Diastereoisomer B (158 mg from 500 mg of diiodide 2, 0.395
mmol, 35%): mp 110-115 °C dec; IR νmax 3350 (w), 3060 (w),
Diastereoisomer B (59 mg from 500 mg of diiodide 6, 0.17
mmol, 13%): IR νmax 3350 (w), 3070 (w), 2970 (w), 1601 (w), 1493
(m), 1449 (m), 1185 (m), 1095 (m), 696 (s) cm-1; 1H NMR (CDCl3)
δ 1.04 (t, J ) 8 Hz, 3H), 2.25 (s, 3H), 3.19 (m, 2H), 3.96 (bs, 2H),
4.88 (q, J ) 8 Hz, 2H), 5.88 (s, 1H), 6.09 (s, 1H), 7.16-7.43 (m,
10H); MS (EI) m/z 352 (M+, 11), 334 (13), 288 (75), 275 (100),
77 (83), 59 (73). Anal. Calcd for C21H24N2O3‚2.5 H2O: C, 63.46;
H, 7.35; N, 7.05. Found: C, 63.59; H, 6.92; N, 7.18.
1
1601 (w), 1466 (m), 1092 (m), 697 (s) cm-1; H NMR (CDCl3) δ
2.80-3.40 (bs, 2H, exch. with D2O), 3.27 (s, 3H), 5.97 (s, 1H),
6.08 (s, 1H), 7.07-7.49 (m, 14H); MS (EI) m/z 404 (M+, 7), 386
(75), 309 (47), 105 (57), 77 (100). Anal. Calcd for C24H21N2O2Cl‚
0.5H2O: C, 69.65; H, 5.36; N, 6.77. Found: C, 69,65; H, 5.48; N,
6.92.
(4′-Ch lor op h en yl)-1-m eth ylim id a zole (10) (132 mg from
500 mg of diiodide 2, 0.69 mmol, 61%): IR νmax 3106 (w), 2953
(w), 1602 (w), 1469 (s), 1092 (s), 1010 (s), 725 (s) cm-1; 1H NMR
(CDCl3) δ 3.73 (s, 3H),6,96 (s, 1H), 7.11 (s, 1H), 7.43 (d, J ) 8.8
Hz, 2H), 7.57 (d, J ) 8.8 Hz, 2H); MS (EI) m/z 192 (M+, 87), 191
(100), 157 (11), 156 (32). Anal. Calcd for C10H9N2Cl‚0.4H2O: C,
60.10; H, 4.94; N, 14.02. Found: C, 60.58; H, 5.35; N, 13.52.
1-Meth yl-2-m eth ylm er ca p toim id a zole-4,5-d ica r boxa ld e-
h yd e (11) (260 mg from 1.47 g of diiodide 3, 1.4 mmol, 37%):
mp 100-103 °C; IR νmax 3054 (w), 2987 (w), 1698 (m), 1672 (m),
Ack n ow led gm en t. We wish to thank Professor S.
H. Hu¨ttenhain of the Fachhochschule Darmstadt, for
useful discussions during the course of this work.
Su p p or tin g In for m a tion Ava ila ble: Copies of 300 MHz
1H NMR spectra for compounds 7-14. This material is
J O0161680